May-June 2019

Abstracts

Comparison of Atherosclerotic Plaque Characteristics among Normal and High Triglycerides (TGs) Patients
• Lavanya Cherukuri,
• Chandana Shekar,
• April Kinninger,
• ...
• Matthew Budoff,
• John Nelson,
• Amit Johanis
Published in issue: May 2019
e22-e23


Meta-analysis of Effects of Triglyceride Modifiers on Cardiovascular Outcomes*
• Hammad Rahman,
• Safi Khan,
• Swapna Talluri,
• Muhammad Asif,
• Tehseen Hammad,
• Edo Kaluski
Published in issue: May 2019
e23-e24


Severe Combined Hyperlipidemia, Heterozygous APOE p.V254E, Pancreatitis, Diabetes Mellitus, and Plantar Xanthomas*
• Brian Cheung,
• Barry Tedder,
• Ernst Schaefer,
• Robert Hegele
Published in issue: May 2019
e24-e25

Familial Chylomicronemia Syndrome is associated with increased dietary fatty acid spillover in the circulation despite lower total postprandial triglycerides
• Andre C. Carpentier,
• Frederique Frisch,
• Diane Brisson,
• Daniel Gaudet
Published in issue: May 2019
e25

Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity
• Etienne Khoury,
• Daniel Gaudet,
• Diane Brisson
Published in issue: May 2019
e25-e26

Free glycerol correlate with post-heparin lipoprotein lipase activity and contribute to differentiate familial vs. multifactorial chylomicronemia
• Diane Brisson,
• Etienne Khoury,
• Daniel Gaudet
Published in issue: May 2019
e26

Lipase Maturation Factor 1 Contributes to ER Redox Homeostasis^†
• Saskia Neher
Published in issue: May 2019
e26-e27

Relationship between Lipid Levels and Coronary Atherosclerotic Plaque Scores by Coronary Computed Tomography Angiography (CTA) in Subjects with Elevated Triglycerides
• Alice Lee,
• April Kinninger,
• Eranthi Jayawardena,
• ...
• Ferdinand Flores,
• Matthew Budoff,
• John Nelson
Published in issue: May 2019
e27


For Whom The Lobe Folded.....When?
• Robert Charles Lichtenberg,
• Jyothsna Bandaru
Published in issue: May 2019
e28

Association between Lipids and Coronary Atherosclerotic Plaque Characteristics
• Lavanya Cherukuri,
• Chandana Shekar,
• April Kinninger,
• ...
• Sion Roy,
• Matthew Budoff,
• John Nelson
Published in issue: May 2019
e28-e29

The Role of Niacin in the Management of Dyslipidemia^†
• Joseph M. Keenan
Published in issue: May 2019
e29-e30

Uncovering barriers and facilitators to caring for familial hypercholesterolemia*
• Laney K. Jones,
• Olivia Schlottmann,
• Alanna Rahm,
• ...
• Christina Gregor,
• Amy Sturm,
• Marc Williams
Published in issue: May 2019
e30

An updated cost-effectiveness analysis of evolocumab therapy for reducing cardiovascular events in very high-risk patients with atherosclerotic cardiovascular disease according to the 2018 ACC/AHA guideline
• Gregg C. Fonarow,
• Ben van Hout,
• Guillermo Villa,
• Jorge Arellano,
• Peter Lindgren
Published in issue: May 2019
e31

Evaluating a population health approach to statin use: pharmacist driven interventions in patients with type 2 diabetes mellitus*
• Kyle A. Troksa,
• Sarah Billups,
• Joseph Saseen
Published in issue: May 2019
e31-e32

Geographic Variation In LDL-C Levels And Lipid Lowering Therapy Use In Patients With Atherosclerotic Cardiovascular Disease
• Seth J. Baum,
• Sasikiran Nunna,
• Pallavi Rane,
• ...
• Mohdhar Habib,
• Xin Wang,
• Rolin Wade
Published in issue: May 2019
e32-e33

Technological advancements in CME increase knowledge gains and the translation of education to practice within cardiovascular care.
• Matthew Frese,
• Brooke Hefele,
• Lauren Welch,
• Christina Gallo,
• Andrew Grzybowski
Published in issue: May 2019
e33

Severe hypercholesterolemia secondary to drug-induced cholestatic liver injury
• Diana Vinh Venci,
• Kelly Bartsch,
• Erica Davidson,
• Abigail Rabatin,
• Michael Milks
Published in issue: May 2019
e34

Perceived Barriers to Lipid Management for Suspected Familial Hypercholesterolemia Franco-American Founder Populations*
• Reed Mszar,
• Sara Buscher,
• Heidi Taylor,
• Dervilla McCann
Published in issue: May 2019
e34-e35


Familial Chylomicronemia Syndrome: Distinguishing the Rare Among the Common in Adults for Appropriate Management^†
• Masako Ueda,
• Frances Burke,
• Denis Sviridov,
• ...
• Robert Hegele,
• Daniel Rader,
• Richard Dunbar
Published in issue: May 2019
e35-e36

Case Presentation: A family history of early myocardial infarction in a family with elevated lipoprotein(a)
• Michael Parker Ayers,
• Daniel Soffer,
• Douglas Jacoby
Published in issue: May 2019
e36

Intensity and Timing of Statin Initiation in Patients with initial LDL Greater Than 190 mg/dL in an Urban Medical Center: A Retrospective Observational Single Center University Experience*
• Sanket R. Gokhale,
• Noreen Nazir
Published in issue: May 2019
e37

Clinical Management of Elevated Lipoprotein(a) in A Large Cohort of Familial Hypercholesterolemia Patients
• Samip Sheth,
• Daniel Rader,
• Douglas Jacoby,
• Daniel Soffer
Published in issue: May 2019
e37-e38

Patient Characteristics and Prescribing Patterns for Patients Approved and Denied PCSK9 Inhibitors in Real-World Practice
• Alexander Blake Smith,
• Drew Johnson,
• Kumar Sarkar,
• Alissa Connelly,
• Dean Karalis
Published in issue: May 2019
e38

Cognitive Function in Patients on Evolocumab*
• Qian Ye,
• Meghana Halkar,
• Max Trenerry,
• Erica Kludtke,
• Stephen Kopecky
Published in issue: May 2019
e38-e39

Homozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry^†
• Marina Cuchel,
• Joshua Knowles,
• Iris Kindt,
• ...
• MacRae Linton,
• Patrick Moriarty,
• Samuel Gidding
Published in issue: May 2019
e39


Characterization of Familial Hypercholesterolemia Management at an Academic Medical Center*
• Danielle Hess,
• Stephanie Seto,
• Pramit Nadpara,
• Evan Sisson,
• Dave Dixon
Published in issue: May 2019
e39-e40

How Can We Reduce Cardiovascular Disease Risks in Black Women?
• Aneesha Thobani,
• Puja Mehta,
• Senait Asier,
• Lian Li,
• Karleigh Murphy,
• Gina Lundberg
Published in issue: May 2019
e40-e41

Evaluation of the Safety Profile of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Chronic Kidney Disease*
• Nubriel Hernandez,
• Roda Plakogiannis,
• Naeem Baalbaki
Published in issue: May 2019
e41

Management of Dyslipidemia in Patients with Dermatomyositis: A Case Series
• Kelly Bartsch,
• Erica Davidson,
• Abigail Rabatin,
• ...
• Michael Milks,
• John Larry,
• Laxmi Mehta
Published in issue: May 2019
e41-e42

Gender Differences in Response to PCSK9 Inhibitor Therapy
• Paul Ziajka
Published in issue: May 2019
e42

Significance of Lipid Management in Cardiac Transplant Population
• Indu Poornima,
• Juliette Power,
• Mark Doyle
Published in issue: May 2019
e42-e43

Race/Ethnic differences in dyslipidemia patterns in Youth
• Nidhi Bansal,
• Kristen Tejtel
Published in issue: May 2019
e43

Importance of Nutritional Intervention for Infants with Abetalipoproteinemia
• Masako Ueda,
• Frances Burke,
• Michelle Maeda,
• ...
• Robert Hegele,
• Mary Malloy,
• Daniel Rader
Published in issue: May 2019
e44

The Role of the Novel Lipokine Palmitoleic Acid in Cardiovascular Health: from Bench to Bedside*
• Zhi-Hong Yang,
• Milton Pryor,
• Maureen Sampson,
• Alexander Sorokin,
• Marcelo Amar,
• Alan Remaley
Published in issue: May 2019
e45

Effects of Conjugated Linoleic Acid (CLA) on HDL-C and Triglyceride levels in Subjects with and without the Metabolic Syndrome: A Systematic Review and Meta-analysis
• Rossana Maria Calderon Moreno,
• Ricardo Correa Marquez,
• Anna Oberg,
• Stefania Papatheodorou
Published in issue: May 2019
e45-e46

Lipid Effects of Dietary Education as a Function of Age and Gender
• Debra Ann Friedrich,
• Paul Ziajka,
• Bernice Boivin,
• Nancy Smith
Published in issue: May 2019
e46

Lifestyle intervention improve the weight and exercise patterns of geriatric depressed patients
• Francisco Eduardo Ramirez
Published in issue: May 2019
e46

Prevalence of Diabetes Mellitus with REDUCE-IT-Like Indications: Ramifications for Residual Risk and Potential Risk Reduction
• John R. Nelson,
• Lihong He,
• Michael Dansinger
Published in issue: May 2019
e46-e47

Comparison of EPA and DHA-Rich Fish Oils on NMR Lipoprotein Metabolism in Adults
• Marcelo Amar,
• Zhihong Yang,
• Maureen Sampson,
• Alexander Sorokin,
• Michael Stagliano,
• Alan Remaley
Published in issue: May 2019
e47

Eicosapentaenoic Acid, Unlike Arachidonic Acid, Maintains Normal Membrane Structure and Cholesterol Distribution Under Conditions of Hyperglycemia
• Samuel Sherratt,
• R. Mason
Published in issue: May 2019
e47-e48

Acute Effects of Curcuminoids, EPA (Omega - 3), Astaxanthin and GLA On Cardiovascular Health
• Divya Birudaraju,
• Lavanya Cherukuri,
• April Kinninger,
• ...
• Ferdinand Flores,
• Sion Roy,
• Matthew Budoff
Published in issue: May 2019
e48-e49


Awarness of Risk factors decrease CVD*
• Erum Sohail Jiva
Published in issue: May 2019
e49-e51

Update on dyslipidemia patterns in Chilean adult population: Findings from the 2016-2017 National Health Survey
• Paulina Mendoza,
• Guadalupe Echeverria
Published in issue: May 2019
e51

Serving the Underserved: Are We Overlooking HoFH Patients?
• Linda C. Hemphill,
• Anne Goldberg,
• G. Hovingh,
• Jerome Cohen,
• Dean Karalis
Published in issue: May 2019
e51-e52

Virtual Patient Simulation Improves Clinical Decision-Making in Dyslipidemia: Success of Online CME
• Jelena Spyropoulos,
• Piyali Shin
Published in issue: May 2019
e52


Effects of Marine Omega-3 Fatty Acids on Cardiovascular Outcomes in Patients with Ischemic Heart Disease: A Meta-Analysis*
• Hammad Ur Rahman,
• Tehseen Hammad,
• Edo Kaluski
Published in issue: May 2019
e52-e53

18-Day Residential Lifestyle Program Improves Lipids
• Francisco Eduardo Ramirez,
• Neil Nedley,
• John Hartman,
• Kendra LeBrun
Published in issue: May 2019
e53

Final Report of the OSLER-1 Study: Long-Term Evolocumab for the Treatment of Hypercholesterolemia
• Michael Koren,
• Marc Sabatine,
• Robert Giugliano,
• ...
• Andrew Hamer,
• Scott Wasserman,
• Frederick Raal
Published in issue: May 2019
e53-e54

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial^†
• Robert Pordy,
• Harvey White,
• Gregory Schwartz,
• ...
• Denis Xavier,
• Andreas Zeiher,
• Gabriel Steg
Published in issue: May 2019
e54-e55

Efficacy and Safety of Triplet Therapy With Bempedoic Acid, Ezetimibe, and Atorvastatin in Patients with Hypercholesterolemia
• Diane MacDougall,
• Lulu Ren Sterling,
• John Rubino,
• Jeffrey Hanselman,
• Stephen Nicholls
Published in issue: May 2019
e55